Skip to main content
Top
Published in: International Urology and Nephrology 4/2010

Open Access 01-12-2010 | Urology – Original Paper

Death with functioning kidney transplant: an obituarial analysis

Authors: Puneet Sood, Yong R. Zhu, Eric P. Cohen

Published in: International Urology and Nephrology | Issue 4/2010

Login to get access

Abstract

Background

Death with a functioning kidney graft (DWFG) is now a major cause of graft loss after renal transplantation, occurring in up to 40% of cases. Its occurrence provides insight into the medical care of subjects with a functioning kidney transplant. In this study, we used the time to DWFG as an endpoint, to test whether improved medical care has contributed to better kidney transplant outcomes.

Methods

We used single-center data from the Milwaukee Regional Medical Center and Froedtert Hospital, on kidney-only transplants from 1969 through 2005. A total of 3,157 kidney transplants were done at our center during this time. There were 714 deaths with functioning kidney. We also recorded the major causes of DWFG over the time period from 1969 through 2005 divided into 3 epochs. The data were analyzed as a serial collection of yearly obituaries.

Results

The time to DWFG has increased to 10 years despite a 20-year increase in the mean age of transplant recipients over the same time period.

Conclusions

Better pre-transplant evaluation, improved treatments for hypertension and hyperlipidemia, improved management of acute myocardial infarction, superior immunosuppressive protocols and better prophylaxis and treatment of infectious diseases have all likely contributed to this trend.
Literature
1.
go back to reference Morris PJ, Johnson RJ, Fuggie SV et al (1999) Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. Lancet 354(9185):1147–1152CrossRefPubMed Morris PJ, Johnson RJ, Fuggie SV et al (1999) Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. Lancet 354(9185):1147–1152CrossRefPubMed
2.
go back to reference Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, Stablein D (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342(9):605–612CrossRefPubMed Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, Stablein D (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342(9):605–612CrossRefPubMed
3.
go back to reference Shimmura H, Tanabe K, Tokumoto T, Ishida H, Ishikawa N, Miyamoto N, Shirakawa H, Toma H (2004) Analysis of cause of death with a functioning graft: a single center experience. Transplant Proc 36(7):2026–2029CrossRefPubMed Shimmura H, Tanabe K, Tokumoto T, Ishida H, Ishikawa N, Miyamoto N, Shirakawa H, Toma H (2004) Analysis of cause of death with a functioning graft: a single center experience. Transplant Proc 36(7):2026–2029CrossRefPubMed
4.
go back to reference El-Agroudy AE, Bakr MA, Shehab EL, Dein AB, Ghoneim MA (2003) Death with functioning graft in living donor kidney transplantation: analysis of risk factors. Am J Nephrol 23(3):186–193CrossRefPubMed El-Agroudy AE, Bakr MA, Shehab EL, Dein AB, Ghoneim MA (2003) Death with functioning graft in living donor kidney transplantation: analysis of risk factors. Am J Nephrol 23(3):186–193CrossRefPubMed
5.
go back to reference Matas AJ, Humar A, Gillingham KJ et al (2002) Five preventable causes of kidney graft loss in the 1990s: a single center analysis. Kidney Int 62(2):704–714CrossRefPubMed Matas AJ, Humar A, Gillingham KJ et al (2002) Five preventable causes of kidney graft loss in the 1990s: a single center analysis. Kidney Int 62(2):704–714CrossRefPubMed
6.
go back to reference Ojo AO, Hanson JA, Wolfe RA et al (2000) Long term survival in renal transplant recipients with graft function. Kidney Int 57 (1):307–313 Ojo AO, Hanson JA, Wolfe RA et al (2000) Long term survival in renal transplant recipients with graft function. Kidney Int 57 (1):307–313
8.
go back to reference Saxena R, Yu X, Giraldo M, Arenas J, Vazquez M, Lu CY, Vaziri ND, Silva FG, Zhou XJ (2009) Renal transplantation in elderly. Int Urol Nephrol 41(1):185–210CrossRef Saxena R, Yu X, Giraldo M, Arenas J, Vazquez M, Lu CY, Vaziri ND, Silva FG, Zhou XJ (2009) Renal transplantation in elderly. Int Urol Nephrol 41(1):185–210CrossRef
9.
go back to reference Ford ES, Ajani UA, Croft JB, Critchley JA, Labarathe DR, Kotke TE, Giles WH, Capewell S (2007) Explaining the decrease in US deaths from coronary disease, 1980–2000. N Engl J Med 356(23):2388–2398CrossRefPubMed Ford ES, Ajani UA, Croft JB, Critchley JA, Labarathe DR, Kotke TE, Giles WH, Capewell S (2007) Explaining the decrease in US deaths from coronary disease, 1980–2000. N Engl J Med 356(23):2388–2398CrossRefPubMed
10.
go back to reference Aakhus S, Dahl K, Wideroe TE (2004) Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-years follow up. Clin Transplant 18(5):596–604CrossRefPubMed Aakhus S, Dahl K, Wideroe TE (2004) Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-years follow up. Clin Transplant 18(5):596–604CrossRefPubMed
11.
go back to reference Ivens K, Aker S, Grabensee B, Heering P (1999) Incidence of Cardiovascular risk factors and complications after kidney transplantation. Med Klin (Munich) 94(9):478–484CrossRef Ivens K, Aker S, Grabensee B, Heering P (1999) Incidence of Cardiovascular risk factors and complications after kidney transplantation. Med Klin (Munich) 94(9):478–484CrossRef
12.
go back to reference Djamali A, Samaniego M, Muth B et al (2006) Medical care of kidney transplant recipients after the first posttransplant year. Clin J Am Soc Nephrol 1(4):623–640CrossRefPubMed Djamali A, Samaniego M, Muth B et al (2006) Medical care of kidney transplant recipients after the first posttransplant year. Clin J Am Soc Nephrol 1(4):623–640CrossRefPubMed
13.
go back to reference Holdaas H, Fellstrom B, Cole E, Nyberg G, Olssan AG, Pettersen TR, Madsen S, Gronhaggen-Riska C, Neumayer HH, Jardine AG (2005) Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study. Am J Transplant 5(12):2929–2936CrossRefPubMed Holdaas H, Fellstrom B, Cole E, Nyberg G, Olssan AG, Pettersen TR, Madsen S, Gronhaggen-Riska C, Neumayer HH, Jardine AG (2005) Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study. Am J Transplant 5(12):2929–2936CrossRefPubMed
14.
go back to reference Cosio FG, Pesavento TE, Pelletier RP, Henry M, Ferguson RM, Kim S, Lemeshow S (2002) Patient survival after renal transplantation. III: The effects of statins. Am J Kidney Dis 40(3):638–643CrossRefPubMed Cosio FG, Pesavento TE, Pelletier RP, Henry M, Ferguson RM, Kim S, Lemeshow S (2002) Patient survival after renal transplantation. III: The effects of statins. Am J Kidney Dis 40(3):638–643CrossRefPubMed
15.
go back to reference Wiesbauer F, Heinz Georg, Mitterbauer C, Harnoncourt F, Horl WH, Oberbauer R Statin use is associated with prolonged survival of renal transplant recipients. J Am Soc Nephrol 19:211–2218 Wiesbauer F, Heinz Georg, Mitterbauer C, Harnoncourt F, Horl WH, Oberbauer R Statin use is associated with prolonged survival of renal transplant recipients. J Am Soc Nephrol 19:211–2218
17.
go back to reference Opelz G, Dohler B (2005) Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 5(11):2725–2731CrossRefPubMed Opelz G, Dohler B (2005) Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 5(11):2725–2731CrossRefPubMed
18.
go back to reference Gottlieb S, Goldbourt U, Boyko V, Harpaz D, Mandelzweig L, Khouty Z, Stern S, Behar S (2000) Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981–1983 and 1992–1994. Eur Heart J 21(4):284–295CrossRefPubMed Gottlieb S, Goldbourt U, Boyko V, Harpaz D, Mandelzweig L, Khouty Z, Stern S, Behar S (2000) Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981–1983 and 1992–1994. Eur Heart J 21(4):284–295CrossRefPubMed
19.
go back to reference Herzog CA, Ma JZ, Collins AJ (2000) Long term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kid Dis 36(1):145–152CrossRefPubMed Herzog CA, Ma JZ, Collins AJ (2000) Long term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kid Dis 36(1):145–152CrossRefPubMed
20.
go back to reference Heinze G, Oberbauer R, Kainz A, Mitterbauer C, Koppelstaetter C, Hörl WH, Mayer G (2009) Calcineutrin inhibitor based immunosuppressive therapy, donor age and long term outcome after kidney transplant. Transplantation 87(12):1821–1829CrossRefPubMed Heinze G, Oberbauer R, Kainz A, Mitterbauer C, Koppelstaetter C, Hörl WH, Mayer G (2009) Calcineutrin inhibitor based immunosuppressive therapy, donor age and long term outcome after kidney transplant. Transplantation 87(12):1821–1829CrossRefPubMed
21.
go back to reference Tilden DP, Chapman J, Davey PJ, Solly ML, Crowley S (2004) A decision-analytic economic evaluation of valaciclovir prophylaxis for the prevention of cytomegalovirus infection and disease in renal transplantation. Clin Transplant 18(3):312–320CrossRefPubMed Tilden DP, Chapman J, Davey PJ, Solly ML, Crowley S (2004) A decision-analytic economic evaluation of valaciclovir prophylaxis for the prevention of cytomegalovirus infection and disease in renal transplantation. Clin Transplant 18(3):312–320CrossRefPubMed
22.
go back to reference Hodson EM, Craig JC, Strippoli GF, Webster AC (2008) Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 16(2):CD003774 Hodson EM, Craig JC, Strippoli GF, Webster AC (2008) Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 16(2):CD003774
23.
go back to reference Hodson EM, Jones CA, Webster AC, Strippoli GF, Barclay PG, Kable K, Vimalachandra D, Craig JC (2005) Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomized controlled trials. Lancet 365(9477):2105–2115CrossRefPubMed Hodson EM, Jones CA, Webster AC, Strippoli GF, Barclay PG, Kable K, Vimalachandra D, Craig JC (2005) Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomized controlled trials. Lancet 365(9477):2105–2115CrossRefPubMed
24.
go back to reference Kiberd BA, Keough-Ryan T, Clase CM (2003) Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant 3(5):619–625CrossRefPubMed Kiberd BA, Keough-Ryan T, Clase CM (2003) Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant 3(5):619–625CrossRefPubMed
25.
go back to reference Wong G, Chapman JR, Craig JC (2008) Cancer screening in renal transplant recipients: what is the evidence? Clin J Am Soc Nephrol 3(Suppl 2):S87–S100CrossRefPubMed Wong G, Chapman JR, Craig JC (2008) Cancer screening in renal transplant recipients: what is the evidence? Clin J Am Soc Nephrol 3(Suppl 2):S87–S100CrossRefPubMed
Metadata
Title
Death with functioning kidney transplant: an obituarial analysis
Authors
Puneet Sood
Yong R. Zhu
Eric P. Cohen
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 4/2010
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-010-9721-z

Other articles of this Issue 4/2010

International Urology and Nephrology 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.